{"id":"allogeneic-adipose-derived-stem-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Pain"},{"rate":"null","effect":"Swelling"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"These cells are derived from fat tissue and are used to promote tissue regeneration and repair. They work by releasing growth factors and other signaling molecules that stimulate the body's natural repair processes.","oneSentence":"Allogeneic adipose-derived stem cells are used to stimulate the body's natural repair processes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:21:32.346Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Orthopedic conditions"}]},"trialDetails":[{"nctId":"NCT06905834","phase":"PHASE2","title":"Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-05","conditions":"Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT06654193","phase":"PHASE1, PHASE2","title":"Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT07077746","phase":"PHASE2","title":"HB-adMSCs for the Treatment of Crohn's Disease","status":"RECRUITING","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-03","conditions":"Crohn Disease (CD)","enrollment":46},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT07367815","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2026-03-01","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT06623240","phase":"PHASE2","title":"HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis","status":"WITHDRAWN","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-01","conditions":"Juvenile Idiopathic Arthritis (JIA)","enrollment":""},{"nctId":"NCT06636032","phase":"PHASE1, PHASE2","title":"Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-03-12","conditions":"Crohn Disease","enrollment":9},{"nctId":"NCT04995081","phase":"PHASE2","title":"Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-07-16","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT07290946","phase":"PHASE2","title":"Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Christian von Buchwald","startDate":"2025-12","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy, Sjögren´s Syndrome","enrollment":100},{"nctId":"NCT05526001","phase":"PHASE3","title":"Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"UnicoCell Biomed CO. LTD","startDate":"2023-07-03","conditions":"Knee Osteoarthritis","enrollment":165},{"nctId":"NCT07164482","phase":"","title":"Intermediate Size Patient Population Expanded Access Protocol to Evaluate HB-adMSCs for the Treatment of Patients With Traumatic or Nontraumatic Brain Injury","status":"AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Brain Injury","enrollment":""},{"nctId":"NCT05789394","phase":"PHASE1","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-06-16","conditions":"Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, Grade IV","enrollment":20},{"nctId":"NCT04087889","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Pancreatic Cancer","enrollment":""},{"nctId":"NCT04348435","phase":"PHASE2","title":"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-05-14","conditions":"COVID-19","enrollment":53},{"nctId":"NCT05126563","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2022-02-02","conditions":"Post COVID-19 Syndrome","enrollment":79},{"nctId":"NCT04362189","phase":"PHASE2","title":"Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19","status":"TERMINATED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-06-30","conditions":"COVID-19","enrollment":48},{"nctId":"NCT04569409","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2020-07-14","conditions":"Diabetic Foot Ulcer","enrollment":104},{"nctId":"NCT06539429","phase":"PHASE1","title":"Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2024-10-22","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT07106229","phase":"PHASE3","title":"A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.","status":"NOT_YET_RECRUITING","sponsor":"Magellan Stem Cells","startDate":"2025-11","conditions":"Knee Osteoarthristis","enrollment":573},{"nctId":"NCT05344157","phase":"PHASE1, PHASE2","title":"A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Xindu Pty Ltd","startDate":"2022-06-22","conditions":"Osteoarthritis, Knee","enrollment":24},{"nctId":"NCT04392206","phase":"PHASE1","title":"AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses","status":"RECRUITING","sponsor":"Houssam Farres, M.D.","startDate":"2020-05-15","conditions":"End Stage Renal Disease","enrollment":15},{"nctId":"NCT06570291","phase":"PHASE3","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Wuxi Cellular Biopharmaceutical Group Ltd.","startDate":"2025-02-28","conditions":"Knee Osteoarthritis","enrollment":520},{"nctId":"NCT04869761","phase":"PHASE1","title":"Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2021-10-07","conditions":"Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT05549609","phase":"PHASE1, PHASE2","title":"A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers","status":"RECRUITING","sponsor":"Xintela AB","startDate":"2022-10-26","conditions":"Venous Leg Ulcer","enrollment":6},{"nctId":"NCT06956807","phase":"PHASE1","title":"Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Viscofan","startDate":"2025-09-01","conditions":"CABG-patients, Heart Failure, Myocardial Infarction (MI)","enrollment":10},{"nctId":"NCT06738576","phase":"PHASE1","title":"Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2024-12-16","conditions":"Urinary Incontinence Stress","enrollment":60},{"nctId":"NCT04466007","phase":"PHASE2","title":"Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2021-01-11","conditions":"Limb Ischemia, Diabetic Foot","enrollment":90},{"nctId":"NCT06280092","phase":"EARLY_PHASE1","title":"Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery","status":"RECRUITING","sponsor":"Sanjeet S. Grewal","startDate":"2024-12-23","conditions":"Epilepsy","enrollment":5},{"nctId":"NCT04075825","phase":"PHASE3","title":"Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula","status":"COMPLETED","sponsor":"Takeda","startDate":"2019-11-05","conditions":"Crohn's Disease, Complex Perianal Fistula","enrollment":150},{"nctId":"NCT05018793","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-12-01","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT03449082","phase":"PHASE2","title":"Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-03-15","conditions":"Lateral Epicondylitis","enrollment":30},{"nctId":"NCT05521672","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease","status":"TERMINATED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2022-10-24","conditions":"Stenosis; Bowel, Crohn Disease","enrollment":2},{"nctId":"NCT06843122","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-03-08","conditions":"Diabetic Foot Ulcer","enrollment":105},{"nctId":"NCT06805448","phase":"PHASE1, PHASE2","title":"Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-01-21","conditions":"Sjorgren's Syndrome","enrollment":40},{"nctId":"NCT06795620","phase":"PHASE1","title":"Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-01","conditions":"Critical Limb Ischemia","enrollment":10},{"nctId":"NCT03754465","phase":"PHASE2","title":"Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2019-01-02","conditions":"Diabetic Foot Ulcer","enrollment":66},{"nctId":"NCT06303752","phase":"PHASE1, PHASE2","title":"Tissue Therapy of Transsphincteric Anal Fistula","status":"RECRUITING","sponsor":"University of Southern Denmark","startDate":"2024-10-09","conditions":"Anal Fistula","enrollment":75},{"nctId":"NCT03279081","phase":"PHASE3","title":"Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)","status":"COMPLETED","sponsor":"Tigenix S.A.U.","startDate":"2017-09-15","conditions":"Crohn's Disease","enrollment":568},{"nctId":"NCT04661644","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia","status":"COMPLETED","sponsor":"S.Biomedics Co., Ltd.","startDate":"2020-11-04","conditions":"Critical Limb Ischemia","enrollment":20},{"nctId":"NCT05362786","phase":"PHASE1","title":"Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2022-07-01","conditions":"Chronic Kidney Diseases","enrollment":14},{"nctId":"NCT03672825","phase":"PHASE1","title":"REcycled CartiLage Auto/Allo IMplantation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-09-13","conditions":"Cartilage Defect","enrollment":25},{"nctId":"NCT04544215","phase":"PHASE1, PHASE2","title":"A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection","status":"SUSPENDED","sponsor":"Ruijin Hospital","startDate":"2020-07-01","conditions":"Drug-resistant","enrollment":60},{"nctId":"NCT06488898","phase":"PHASE2","title":"Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts","status":"RECRUITING","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2024-06-13","conditions":"Aortic Aneurysm, Abdominal","enrollment":8},{"nctId":"NCT05520086","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.","status":"UNKNOWN","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2022-11-11","conditions":"Chronic Conjunctivitis, Stevens-Johnson Syndrome, Lyell Syndrome","enrollment":20},{"nctId":"NCT05933434","phase":"PHASE1, PHASE2","title":"Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-03-07","conditions":"Knee Osteoarthritis","enrollment":80},{"nctId":"NCT03706456","phase":"PHASE3","title":"Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease","status":"COMPLETED","sponsor":"Takeda","startDate":"2019-03-06","conditions":"Complex Perianal Fistulas in Adult Participants With Crohn's Disease","enrollment":22},{"nctId":"NCT06397274","phase":"PHASE2","title":"Stemchymal® for Polyglutamine Spinocerebellar Ataxia","status":"NOT_YET_RECRUITING","sponsor":"Steminent US, Inc.","startDate":"2025-06-01","conditions":"Spinocerebellar Ataxias","enrollment":20},{"nctId":"NCT04992247","phase":"PHASE2","title":"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 \"Long Haul\" Pulmonary Compromise","status":"WITHDRAWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2024-02","conditions":"Covid19","enrollment":""},{"nctId":"NCT04289194","phase":"PHASE1, PHASE2","title":"Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Histocell, S.L.","startDate":"2019-12-10","conditions":"Acute Respiratory Distress Syndrome","enrollment":26},{"nctId":"NCT02933827","phase":"PHASE1, PHASE2","title":"Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease","status":"COMPLETED","sponsor":"UnicoCell Biomed CO. LTD","startDate":"2018-05-01","conditions":"Moderate to Severe Chronic Kidney Disease","enrollment":39},{"nctId":"NCT05017298","phase":"PHASE2","title":"Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Celltex Therapeutics Corporation","startDate":"2024-11-01","conditions":"Corona Virus Infection, Covid19","enrollment":30},{"nctId":"NCT06141317","phase":"PHASE1, PHASE2","title":"Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)","status":"UNKNOWN","sponsor":"ClusterXStem-Costa Rica","startDate":"2023-06-23","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT03878628","phase":"EARLY_PHASE1","title":"Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2019-10-16","conditions":"Dry Eye, Kerato Conjunctivitis Sicca, Aqueous Tear Deficiency","enrollment":7},{"nctId":"NCT04388761","phase":"PHASE1","title":"Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)","status":"WITHDRAWN","sponsor":"Tambi Jarmi","startDate":"2020-09","conditions":"Ischemia Reperfusion Injury","enrollment":""},{"nctId":"NCT04776538","phase":"PHASE2","title":"Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2021-02-09","conditions":"Xerostomia Following Radiotherapy","enrollment":120},{"nctId":"NCT03370874","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2018-06-27","conditions":"Diabetic Foot Ulcer","enrollment":150},{"nctId":"NCT03183661","phase":"","title":"A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial","status":"RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2016-11-16","conditions":"Crohn Disease","enrollment":9},{"nctId":"NCT03183934","phase":"","title":"A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2017-12-08","conditions":"Dystrophic Epidermolysis Bullosa","enrollment":2},{"nctId":"NCT03265613","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis","status":"COMPLETED","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2017-09-24","conditions":"Mesenchymal Stromal Cells, Psoriasis, Drug Toxicity","enrollment":7},{"nctId":"NCT01440699","phase":"PHASE1","title":"Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2011-09","conditions":"Crohn","enrollment":6},{"nctId":"NCT02580617","phase":"PHASE1","title":"A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease","status":"UNKNOWN","sponsor":"Anterogen Co., Ltd.","startDate":"2015-11-09","conditions":"Crohn's Disease","enrollment":9},{"nctId":"NCT03183648","phase":"","title":"A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2016-08-29","conditions":"Burn","enrollment":14},{"nctId":"NCT03392311","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis","status":"COMPLETED","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2019-07-23","conditions":"Mesenchymal Stromal Cells, Psoriasis, Drug Effect","enrollment":8},{"nctId":"NCT04785027","phase":"PHASE1, PHASE2","title":"Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis","status":"UNKNOWN","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2021-03-17","conditions":"Traditional Chinese Medicine, Drug Effect, Drug Safety","enrollment":16},{"nctId":"NCT04497805","phase":"PHASE2","title":"Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers","status":"UNKNOWN","sponsor":"Anterogen Co., Ltd.","startDate":"2020-09-08","conditions":"Diabetic Foot Ulcer","enrollment":64},{"nctId":"NCT04208646","phase":"PHASE2","title":"Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Shanghai AbelZeta Ltd.","startDate":"2020-05-16","conditions":"Knee Osteoarthritis","enrollment":106},{"nctId":"NCT05962931","phase":"PHASE1, PHASE2","title":"Clinical Trial With Adipose Tissue Stem Cells on Biological Matrix for the Treatment of Venous Ulcer of the Lower Limbs","status":"UNKNOWN","sponsor":"Andalusian Network for Design and Translation of Advanced Therapies","startDate":"2023-07-12","conditions":"Venous Ulcer","enrollment":20},{"nctId":"NCT03943576","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Gwo Xi Stem Cell Applied Technology Co., Ltd.","startDate":"2019-12-01","conditions":"Knee Osteoarthritis","enrollment":25},{"nctId":"NCT04280003","phase":"PHASE2","title":"Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2021-01-20","conditions":"Ischemic Stroke, Adipose Tissue-derived Stem Cell, Functional Status","enrollment":30},{"nctId":"NCT04615455","phase":"PHASE2","title":"Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2020-11-03","conditions":"Keratoconjunctivitis Sicca, in Sjogren's Syndrome","enrollment":40},{"nctId":"NCT05742100","phase":"","title":"Darvadstrocel for Crohn's Fistula in the Realworld","status":"COMPLETED","sponsor":"Dolores Herreros Marcos","startDate":"2019-11-29","conditions":"Crohn's Fistula","enrollment":73},{"nctId":"NCT04527224","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Nature Cell Co. Ltd.","startDate":"2022-10-24","conditions":"Covid19 Pneumonia","enrollment":10},{"nctId":"NCT04903327","phase":"PHASE2","title":"Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress","status":"TERMINATED","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2021-11-16","conditions":"Covid19","enrollment":43},{"nctId":"NCT03629015","phase":"PHASE1","title":"Safety Study of Stemchymal® in Acute Liver Failure","status":"WITHDRAWN","sponsor":"Steminent Biotherapeutics Inc.","startDate":"2018-10-01","conditions":"Stem Cells, Adult Stem Cells, Acute Liver Failure","enrollment":""},{"nctId":"NCT02687646","phase":"PHASE1, PHASE2","title":"Clinical Trial With MSC for Graft Versus Host Disease Treatment","status":"COMPLETED","sponsor":"Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud","startDate":"2017-02-20","conditions":"Acute Graft Versus Host Disease","enrollment":16},{"nctId":"NCT03509025","phase":"PHASE2","title":"Follow-up Study for Participants Jointstem Clinical Trial","status":"COMPLETED","sponsor":"R-Bio","startDate":"2017-02-08","conditions":"Knee Osteoarthritis","enrollment":11},{"nctId":"NCT04825730","phase":"NA","title":"Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy","status":"NOT_YET_RECRUITING","sponsor":"R-Bio","startDate":"2023-12-01","conditions":"Degenerative Arthritis, Knee Arthritis","enrollment":14},{"nctId":"NCT03092284","phase":"PHASE2","title":"Allogeneic Stem Cell Therapy in Heart Failure","status":"COMPLETED","sponsor":"JKastrup","startDate":"2015-09","conditions":"Heart Failure","enrollment":81},{"nctId":"NCT05322057","phase":"","title":"Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-10-01","conditions":"Crohn Disease, Fistula Perianal","enrollment":14},{"nctId":"NCT04905836","phase":"PHASE2","title":"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress","status":"UNKNOWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2021-11-16","conditions":"Covid19","enrollment":60},{"nctId":"NCT04366323","phase":"PHASE1, PHASE2","title":"Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19","status":"COMPLETED","sponsor":"Andalusian Network for Design and Translation of Advanced Therapies","startDate":"2020-04-27","conditions":"Sars-CoV2","enrollment":26},{"nctId":"NCT03158727","phase":"PHASE1, PHASE2","title":"Cx611-0204 SEPCELL Study","status":"COMPLETED","sponsor":"Tigenix S.A.U.","startDate":"2017-01-30","conditions":"Bacterial Pneumonia","enrollment":84},{"nctId":"NCT01856140","phase":"EARLY_PHASE1","title":"Treatment of Tendon Injury Using Mesenchymal Stem Cells","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2013-05","conditions":"Lateral Epicondylitis","enrollment":12},{"nctId":"NCT04486001","phase":"PHASE1","title":"Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19","status":"COMPLETED","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2020-12-15","conditions":"Covid19","enrollment":10},{"nctId":"NCT02298023","phase":"PHASE2","title":"Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-09","conditions":"Rotator Cuff Tear","enrollment":24},{"nctId":"NCT03865394","phase":"PHASE1, PHASE2","title":"Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2019-07-01","conditions":"Diabetic Foot Ulcer","enrollment":46},{"nctId":"NCT04909879","phase":"PHASE2","title":"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome","status":"WITHDRAWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2021-09","conditions":"Acute Respiratory Distress Syndrome, Ards","enrollment":""},{"nctId":"NCT02917291","phase":"PHASE1, PHASE2","title":"Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury","status":"UNKNOWN","sponsor":"Ferrer Internacional S.A.","startDate":"2016-12","conditions":"Acute Traumatic Spinal Cord Injury","enrollment":48},{"nctId":"NCT04728698","phase":"PHASE2","title":"Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress","status":"WITHDRAWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2021-03","conditions":"Covid19, ARDS","enrollment":""},{"nctId":"NCT04909892","phase":"PHASE2","title":"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 \"Long Haul\" Pulmonary Compromise","status":"WITHDRAWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2021-08","conditions":"Covid19","enrollment":""},{"nctId":"NCT02784964","phase":"PHASE1, PHASE2","title":"Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis","status":"COMPLETED","sponsor":"UnicoCell Biomed CO. LTD","startDate":"2016-03","conditions":"Knee Osteoarthritis","enrollment":57},{"nctId":"NCT04388982","phase":"PHASE1, PHASE2","title":"the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2020-07-01","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT03920397","phase":"NA","title":"Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2015-03-01","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT04889963","phase":"EARLY_PHASE1","title":"Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium","status":"UNKNOWN","sponsor":"Gadjah Mada University","startDate":"2021-01-01","conditions":"Adypose Mesenchimal Stem Cell, Ligament Rupture, Ligament Derived Conditined Medium","enrollment":16},{"nctId":"NCT04348461","phase":"PHASE2","title":"BAttLe Against COVID-19 Using MesenchYmal Stromal Cells","status":"SUSPENDED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2020-05-06","conditions":"COVID, Respiratory Distress Syndrome","enrollment":100},{"nctId":"NCT03874572","phase":"PHASE1","title":"Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2019-03-18","conditions":"Xerostomia Due to Radiotherapy, Hyposalivation, Xerostomia","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":47,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Celltex-AdMSCs"],"phase":"phase_2","status":"active","brandName":"Allogeneic adipose-derived stem cells","genericName":"Allogeneic adipose-derived stem cells","companyName":"Celltex Therapeutics Corporation","companyId":"celltex-therapeutics-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"Allogeneic adipose-derived stem cells are used to stimulate the body's natural repair processes. Used for Orthopedic conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}